New obesity discovery shows experimental drug cuts liver fat by over 30% in phase 3 trial
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
An experimental drug has been found to reduce liver fat by over 30% in a phase 3 trial. This discovery is related to obesity treatment. The trial results indicate a significant reduction in liver fat, suggesting potential for the drug in addressing obesity.